# Amyris acquisition of Oobli

> Developing situation record from CLSTR: https://clstr.news/situations/amyris-acquisition-of-oobli
> Updated: 2026-11-16T21:34:13.000Z. Sources: 4. Developments: 2.

Biomanufacturing company Amyris announced an agreement to acquire Oobli, a developer of fermentation-produced sweet proteins. The acquisition is intended to merge Amyris’ industrial fermentation and strain engineering capabilities with Oobli’s proprietary technology, which is designed to reduce sugar in food and beverage products.

Oobli has spent approximately ten years developing processes to produce sweet proteins, such as brazzein, monellin, and thaumatin, through fermentation. These proteins occur naturally in rare equatorial fruits and berries but are difficult to harvest at scale. By inserting DNA sequences into yeast strains, Oobli can produce these proteins in fermentation tanks. These ingredients are hundreds to thousands of times sweeter than conventional sugar and are metabolized by the body as protein, which may help prevent blood sugar spikes. The proteins hold FDA Generally Recognized as Safe (GRAS) status.

The transaction follows Amyris’ recent expansion of manufacturing capacity at its fermentation facility in Barra Bonita, Brazil. The combined entity intends to apply these technologies across several sectors, including food and beverage, personal care, flavors, fragrances, and agriculture. The purchase price was not disclosed, and the deal is expected to close in the coming weeks.

## Timeline

### 2026-11-16: Amyris to acquire sweet protein innovator Oobli

Biomanufacturing firm Amyris is acquiring Oobli to expand its production of fermentation-derived sweet proteins designed to reduce sugar in food and beverage products.

2 sources. https://clstr.news/cluster/amyris-to-acquire-sweet-protein-innovator-oobli

### 2026-11-13: Amyris to acquire Oobli to expand sweet protein technology

Amyris is acquiring Oobli to integrate fermentation-based sweet protein technology, aiming to help food and beverage brands reduce sugar content using proteins like brazzein and monellin.

2 sources. https://clstr.news/cluster/amyris-to-acquire-oobli-to-expand-sweet-protein-technology

---
Cite as: Amyris acquisition of Oobli. CLSTR, https://clstr.news/situations/amyris-acquisition-of-oobli
